|
Market Closed -
NYSE
12:42:16 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 32.77 USD | -1.55% |
|
+4.48% | +1.39% |
| Current month | +0.07% | ||
| 1 month | +0.26% |
Main features
| US46436E3532 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (INR) | 83.98Cr | Replication Method | Direct (Physical) |
| Number of securities | 60 | AuM evolution | - | Date of creation | 24/08/2022 |
| Name |
Indicative Price |
Change |
Weight | |
|---|---|---|---|---|
 | 144.43USD | +0.68% | 4.89% | |
| 285.93USD | -0.93% | 4.75% | |
| 37.41USD | -0.35% | 3.98% | |
| 59.97USD | -6.97% | 3.93% | |
| 43.90USD | -0.63% | 3.91% | |
| 20.59USD | -0.82% | 3.89% | |
| 253.62USD | +1.59% | 3.88% | |
| 45.34USD | -0.07% | 3.79% | |
| 892.87USD | -0.55% | 3.73% | |
| 146.10USD | -0.19% | 3.65% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | Healthcare Technology & Innovation |
The iShares Neuroscience and Healthcare ETF (the Fund) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $32.77 | -1.55% | 1,768 |
| 29/26/29 | $33.29 | +1.11% | 2,186 |
| 28/26/28 | $32.92 | +2.11% | 998 |
| 27/26/27 | $32.24 | +2.03% | 2,665 |
| 26/26/26 | $31.60 | +0.75% | 1,062 |
- Stock Market
- ETF
- IBRN ETF
Select your edition
All financial news and data tailored to specific country editions
